Clinical Features and Disease Haplotypes of Individuals With the N279K tau Gene Mutation: A Comparison of the Pallidopontonigral Degeneration Kindred and a French Family
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An N279K missense mutation in exon 10 of the tau gene reported in an American family with pallidopontonigral degeneration (PPND family) was recently found in members of a French kindred with dementia and supranuclear palsy. OBJECTIVES: To compare clinical phenotypes of both families and to perform genealogical and molecular genetic studies to determine whether they are derived from a common founder. DESIGN AND METHODS: We performed clinical examinations of affected members of both families and compared clinical phenotypes, existing genealogical family records, and chromosome 17 microsatellite repeat markers in the vicinity of the tau gene. RESULTS: The inheritance pattern is autosomal dominant in the PPND family and appears so in the French family. Average age at onset of clinical symptoms was 43 years in the PPND family and 41 years in the French family. Mean disease duration was 8 years in the PPND family and 6 years in the French family. Parkinsonism, personality changes, and dementia of the frontotemporal type were seen in both kindreds. All affected patients exhibited rapidly progressive parkinsonism characterized by bradykinesia, tremor, postural instability, and rigidity. Some had a transient response to levodopa therapy during the initial stages. Pyramidal signs and eye movement abnormalities, including supranuclear gaze palsy, were common. Results of linkage studies of the tau region in chromosome 17 did not reveal a haplotype common to both kindreds. CONCLUSIONS: Affected members from both families had more clinical similarities than differences. Results of genealogical and molecular genetic studies determined that the families were not related. The N279K mutations found in both families have independent origins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 1×
“However, in multiple-system tauopathy with presenile dementia, affected members had a mutation at intron +3 after exon 10 and presented with parkinsonism and vertical gaze palsy accompanied by dementia and disinhibition.(24,25) Recently, a family with a novel mutation of S305S (E10 –1) was described.”
BackgroundSelf-citationFrontotemporal Dementia and Corticobasal Degeneration in a Family with a P301S Mutation in Tau
Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., Morbin, M., Primavera, A., Carella, F., Solaro, C., et al. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00011 · Cited by 450
Self-citationSumi, S. M., Bird, T. D., Nochlin, D., & Raskind, M. A. (1992) · Neurology · doi:10.1212/wnl.42.1.120 · Cited by 118
Cited by
The role of tau (MAPT) in frontotemporal dementia and related tauopathies
Rademakers, R., Cruts, M., & van Broeckhoven, C. (2004) · Human Mutation · doi:10.1002/humu.20086 · Cited by 356
Essential tremor — Neurodegenerative or nondegenerative disease towards a working definition of ET
Deuschl, G., & Elble, R. (2009) · Movement Disorders · doi:10.1002/mds.22755 · Cited by 232
Ikeda, A., Shimada, H., Nishioka, K., Takanashi, M., Hayashida, A., Li, Y., Yoshino, H., Funayama, M., Ueno, Y., Hatano, T., et al. (2019) · Movement Disorders · doi:10.1002/mds.27623 · Cited by 22
Diagnosing progressive supranuclear palsy: Role of biological and neuroimaging markers
Benussi A, B. B. (2014) · Journal of Alzheimer's Disease & Parkinsonism · doi:10.4172/2161-0460.1000168 · Cited by 6
“be/FTDMutations/) only 9 have been associated with a PSP phenotype [27-36] (see Table 1).”
BackgroundLarge-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity
Magalhães, A. D., Emmenegger, M., De Cecco, E., Carta, M., Frontzek, K., Chincisan, A., Guo, J., Hornemann, S., & Aguzzi, A. (2025) · PLOS Biology · doi:10.1371/journal.pbio.3003488 · Cited by 2
“Seroepidemiological studies cannot establish causality: ατ seropositivity could be a cause or a consequence of the clinical syndromes associated with it [36].”
Metadata
- Authors
- Tsuboi, Y., Uitti, R. J., Delisle, M.-B., Ferreira, J. J., Brefel-Courbon, C., Rascol, O., Ghetti, B., Murrell, J. R., Hutton, M., Baker, M., & Wszolek, Z. K.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-06-01
- Volume
- 59
- Issue
- 6
- Pages
- 943
- ISSN
- 0003-9942
- OpenAlex
- W2155893343
- Cited by
- 37
- References
- 3
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Features and Disease Haplotypes of Individuals With the N279K tau Gene Mutation: A Comparison of the Pallidopontonigral Degeneration Kindred and a French Family. https://app.cochat.ai/papers/10.1001/archneur.59.6.943
- The paper
- Tsuboi, Y., Uitti, R. J., Delisle, M.-B., Ferreira, J. J., Brefel-Courbon, C., Rascol, O., Ghetti, B., Murrell, J. R., Hutton, M., Baker, M., & Wszolek, Z. K. (2002). Clinical Features and Disease Haplotypes of Individuals With the N279K tau Gene Mutation: A Comparison of the Pallidopontonigral Degeneration Kindred and a French Family. Archives of Neurology. https://doi.org/10.1001/archneur.59.6.943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.